N = 90
| |
---|---|

Female, n (%)
| 39 (43) |

Age, mean (SD) | 61.5 (14) |

Body mass index (Kg/m^{2}), median (25th–75th percentile)
| 28.6 (24.4–32) |

SAPS II at ICU admission, median (25th–75th percentile) | 42.5 (31–57) |

No. of admissions to ICU within the last year, n (%)
| 4 (4.4) |

Main diagnosis
| |

Pneumonia, n (%)
| 32 (35) |

Sepsis, n (%)
| 8 (9) |

COPD/asthma exacerbation, n (%)
| 12 (13) |

Cardiac failure, n (%)
| 12 (13) |

Drug overdose/acute mental status change, n (%)
| 11 (12) |

Intra-abdominal sepsis with surgery, n (%)
| 14 (15) |

Trauma, n (%)
| 1 (4) |

Co-morbidity
| |

Chronic pulmonary disease, n (%)
| 23 (25) |

Obesity, n (%)
| 27 (30) |

Chronic cardiac insufficiency, n (%)
| 13 (14) |

Cancer, n (%)
| 15 (17) |

Chronic kidney disease, n (%)
| 14 (15) |

Diabetes mellitus, n (%)
| 17 (19) |

Between admission and awakening
| |

Septic shock, n (%)
| 45 (50) |

ARDS, n (%)
| 13 (14) |

Renal failure, n (%)
| 30 (33) |

Use of catecholamines, n (%)
| 58 (64) |

Use of neuromuscular blockers, n (%)
| 58 (64) |

No. of days of neuromuscular blockers, median (25–75th percentile) | 1 (0–3) |

Use of corticosteroids, n (%)
| 21 (78) |

Ventilator use (days), median (25th–75th percentile) | 7 (4–9) |